Connect with us

Health

Weighing risks and benefits of COVID-19 vaccination in children – Medical Xpress

The U.S. Food and Drug Administration has approved Pfizer’s COVID-19 vaccine for use in children ages five to 11. Pfizer’s clinical…

Published

on

Article feature image

The U.S. Food and Drug Administration has approved Pfizer’s COVID-19 vaccine for use in children ages five to 11. Pfizer’s clinical trial results indicate the vaccine is safe and effective in this age group.
This is an important development. COVID-19 infectionsare…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending